Increases in glucocorticoid levels have been found to relate to the degree of dementia in elderly people and AD patients; glucocorticoid exposure can trigger incorrect processing of amyloid precursor protein (APP) and reduce the Aβ clearance rate, thereby inducing cognitive dysfunction [112]. Here, APP is linked to Alzheimer disease.